Hence, decreased rs11591147 (p.Arg46Leu) and increased rs499883 in patients with FH leads to increased PCSK9 levels, which strengthens the binding of PCSK9 to LDLR for lysosomal degradation, resulting in insufficient LDLR for recycling. Here, LDLR is linked to familial hyperaldosteronism.